Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2023-09-18 00:00:00 ET · period of report 2023-09-14 · accession 0000895345-23-000533 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-09-18	2023-09-14+	CLOV	Reynoso Jamie L.	CEO of Medicare Advantage	F - Tax	$1.13	-29.3K	1.97M	-1%	-$33.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-09-15	F	D	21,511	$1.13	1,951,083	D	—	—	(F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 15, 2023, of 25% of the original number of RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after September 15, 2023, in each case subject to the continued service of the Reporting Person on such vesting date.
2	Common	Class A Common Stock	2023-09-14	F	D	7,776	$1.13	1,972,594	D	—	—	(F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.